Last reviewed · How we verify
Nicotine Pouches
At a glance
| Generic name | Nicotine Pouches |
|---|---|
| Also known as | Zyn, ZYN |
| Sponsor | Johns Hopkins University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effects of E-cigs vs Pouches on Cigarette Smoking and Addiction (NA)
- Nordic Spirit Pouch Nicotine Pharmacokinetics Abuse Liability (PHASE1)
- Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers (NA)
- Effect of Product Characteristics on the Abuse Liability of Nicotine Pouches (NA)
- Exploratory Randomized, Controlled, Dose-response Study on the Impact of Nicotine From Five Variants of a Nicotine Tablet (NICOTINE TABLET) on Attention (NA)
- Acute Effects of Oral Nicotine Pouches (PHASE1)
- Oral Nicotine Pouch Marketing Features Influence on Perceptions (NA)
- Comparison of Demand and Substitution for Nicotine Pouches as a Function of Nicotine Dosage (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nicotine Pouches CI brief — competitive landscape report
- Nicotine Pouches updates RSS · CI watch RSS
- Johns Hopkins University portfolio CI